Key result
A 47-year-old female with HIV and no history of intravenous drug use successfully recovered from rare isolated native tricuspid valve endocarditis caused by Streptococcus pneumoniae after treatment with intravenous ceftriaxone.
Why the study?
Pneumococcal endocarditis is rare and carries a poor prognosis, particularly as isolated native tricuspid valve endocarditis in patients lacking common risk factors.
Case Report (n=1)
No
This case highlights a rare presentation of isolated native tricuspid valve endocarditis caused by Streptococcus pneumoniae in an HIV patient without typical risk factors like intravenous drug use.
Answers are grounded in this paper and cite their sources.
Isolated native tricuspid pneumococcal endocarditis can occur in HIV without IV drug use; leaves open questions on pathogenesis and management in immunocompromised patients.
Streptococcus pneumonia is an important cause of septicemia. Other sites of infection include meningitis, septic arthritis, and endocarditis. Pneumococcal endocarditis is rare and has a poor prognosis. We report a case of a 47-year-old female patient with HIV who developed isolated native tricuspid valve endocarditis secondary to streptococcus pneumonia, which is considered to be a very rare presentation in our patient due to the absence of common risk factors such as intravenous drug use, heart disease, or right heart catheterization.
No takes yet. Share an insight, caveat, or question.
Manasrah et al. (2020) conducted a case report in Isolated native tricuspid valve endocarditis (n=1). Ceftriaxone was evaluated on Clinical recovery. A 47-year-old female with HIV and no history of intravenous drug use successfully recovered from rare isolated native tricuspid valve endocarditis caused by Streptococcus pneumoniae after treatment with intravenous ceftriaxone.
Synapse has enriched 10 related papers. Consider them for comparative context: